[ET Net News Agency, 16 July 2019] Dawnrays Pharmaceutical (Holdings) Limited (02348)
said "Levocetirizine Dihydrochloride Tablets 5mg", an anti-allergic drug of Suzhou
Dawnrays Pharmaceutical Co., Ltd., a subsidiary of the group (Suzhou Dawnrays), has been
granted approval by National Medical Products Administration for passing the consistency
of quality and efficacy evaluation of generic drugs.
Meanwhile, an anti-infective drug of Suzhou Dawnrays, "Cefoperazone Sodium and
Tazobactam Sodium for Injection (4:1) 1.0g and 2.0g", has obtained approval for drug
registration by the National Medical Products Administration.
With the effect of selective histamine H1 receptor antagonist, Levocetirizine
Dihydrochloride is an anti-allergic drug commonly used clinically for curing
allergy-related syndromes of diseases such as seasonal allergic rhinitis, perennial
allergic rhinitis and chronic idiopathic urticaria.
Cefoperazone Sodium and Tazobactam Sodium for Injection (4:1) is a an anti-infective
compound combination of Cefoperazone Sodium, the third generation of the cephalosporins,
and Tazobactam Sodium. (RC)